Business in the Burbs

Electro-Optical announces positive study results for melanoma device

February

Electro-Optical Sciences Inc. of Irvington announced positive results from a study of MelaFind, an instrument the company is developing to help doctors detect melanoma, a deadly form of skin cancer.

The study, involving 1,383 patients at seven treatment centers nationally, found that MelaFind had a 98 percent success rate in detecting melanoma. The company said that it expects to soon submit an application seeking approval of the device with the U.S. Food and Drug Administration.

“MelaFind appears to be an excellent tool to help detect melanoma at the earliest, most treatable stage,” Gary D. Monheit, associate clinical professor of dermatology at the University of Alabama in Birmingham and the lead investigator for the MelaFind trial, said in a written statement.

This entry was posted on Friday, February 13th, 2009 at 3:34 pm by Jay Loomis. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.